Cancer Data Sciences Annual Lunch Workshop

The Cancer Data Sciences Workshop began in 2003 and are held annually. This annual workshop, sponsored by the Dana-Farber Harvard Cancer Center (DF/HCC), discusses topics related to biostatistics and computational biology as well as topics from related departments, such as population science and cancer biology. The purpose of the workshop is to bring program members together to learn about emerging areas in cancer research with substantial statistical content and encourage new collaborations. Speakers come from both inside and outside the DF/HCC community.

Registration is required for the workshop and space can be limited. Hosts for the event are Franziska Michor, Xihong Lin, and Peter Park.  

To suggest for a seminar topic, please email

2019 Workshop: 3D Architecture of the Genome

Tuesday May 14th
Dana-Farber Cancer Institute
Smith Building Room 308/309


What do we see from Hi-C
Johan Gibcus, Research Instructor at University of Massachusetts Medical School

Identifying structural alterations from 3D interaction maps

Peter Park, Professor of Biomedical Informatics, Harvard Medical School

Structure and formation of mitotic chromosomes
Anton Goloborodko, Postdoctoral Fellow, Massachusetts Institute of Technology

Two mechanisms of chromosome organization
Leonid Mirny, Professor of Medical Engineering and Science, and Physics, Massachusetts Institute of Technology

Lunch is provided.

Hosts: Franziska Michor, PhD; Xihong Lin, PhD; Peter Park, PhD.

Previous Seminars

Machine Learning in Radiology and Pathology

Thursday May 17th
Dana-Farber Cancer Institute.


Andrew Beck, MD, PhD
Associate Professor, Department of Pathology, Harvard Medical School
President and CEO of Path AI

Michael Rosenthal, MD, PhD
Assistant Professor, Radiology, Harvard Medical School
Staff Radiologist, Imaging, Dana-Farber Cancer Institute
Assistant Professor, Radiology, Brigham And Women's Hospital

Matthew Rosen, PhD
Assistant Professor of Radiology, Harvard Medical School

Hosts: Franziska Michor, PhD; Xihong Lin, PhD; Peter Park, PhD.
Computational Metablomics of Cancer and the Microbiome

June 2, 2018
Yawkey Conference Center, Dana-Farber Cancer Institute

Wendy Garrett, MD, PhD
Professor, Department of Immunology and Infectious Diseases, Department of Genetics and Complex Diseases, Harvard TH Chan School of Public Health
Department of Medicine, Harvard Medical School
"Pre-clinical models and mechanistic microbiome studies"

Clary Clish, PhD
Director of the Metabolomics Platform at the Broad Institute of MIT and Harvard
“Application of metabolomics to discover metabolic associations with disease and the gut microbiome”

Curtis Huttenhower, PhD
Associate Professor of Computational Biology and Bioinformatics
Department of Biostatistics
Harvard TH Chan School of Public Health
“Integrating functional molecular profiles of the gut microbiome”
Statisticians impacting clinical care: practice-changing clinical trials

October 9, 2015 12:00-3:00pm
Dana-Farber Cancer Institute, Yawkey Conference Center

Practice Changing Trials from ECOG-ACRIN
Judith Manola, MS
Dana-Farber Cancer Institute

The International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium (IMDC) Prognostic Model: Development, Validation, and Relevance in Clinical Practice
Wanling Xie, MS
Dana-Farber Cancer Institute

Changing the Care of Breast Cancer: The IBCSG Statistical Center
Meredith Regan ScD
Associate Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School

Followed by a panel discussion with Giovanni Parmigiani,
David Schoenfeld, Robert Gray and Rebecca Betensky

Methods for Comparative Effectiveness Research in Cancer

June 11, 2011
Dana-Farber Cancer Institute, Smith Building Room 308/309

CER with Big Administrative Data: Bayesian Methods for Confounding Uncertainty and Treatment Effect Heterogeneity
Francesca Dominici, Ph.D.

Hybrid Design for Comparative Effectiveness Research
Hajime Uno, Ph.D

Decision Analysis for Comparative Effectiveness Research: The Case of Cervical Cancer Prevention
Jane Kim, Ph.D.

Methods for Comparative Effectiveness Research in Cancer Panel discussion to follow with Giovanni Parmigiani, Sharon-Lise Normand, Dianne Finkelstein, and Mary Beth Landrum.

DF/HCC Biostatistics & Computational Biology Program Workshop

Wednesday May 23, 2012
12:00 – 2:30PM
Dana-Farber Cancer Institute, Dana 1620

The role of higher order chromatin structure in the generation of genomic aberrations
Franziska Michor, PhD
Associate Professor of Computational Biology Dana-Farber Cancer Institute, Harvard School of Public Health

Somatic copy number alterations across human cancers
Matthew Meyerson, MD, PhD
Professor of Pathology, Dana-Farber Cancer Institute, Harvard Medical School

New Mechanisms for Genome Evolution
David Pellman, MD
Professor of Pediatric Oncology
Dana-Farber Cancer Institute, Harvard Medical School

Nature versus Nurture: Genomic and Epigenomic Studies on Cancer Risk Associations

June 1, 2011
Dana-Farber Cancer Institute, Center for Life Sciences Building, room 11081

Introductory Remarks
Myles Brown, M.D.

Parity-associated changes in the human breast and their relevance to breast cancer
Kornelia Polyak, M.D., Ph.D. 

Annotating non-protein coding risk alleles discovered through genome wide association studies
Matthew Freedman, M.D. 

Transcriptome and epigenome analyses in cancer risk studies
X. Shirley Liu, Ph.D.

Screening for Cancer: Risks, Models, Costs and Controversies

April 22, 2010
Smith Family Room, Dana-Farber Cancer Institute

Screening for Chronic Diseases: Background and Preliminaries
Introductory remarks by Marvin Zelen, PhD

The Firestorm Unleashed by the New USPSTF Mammography Recommendations
Judy E. Garber, MD, MPH

Spending Healthcare Resources Wisely: Cost-effectiveness of Cancer Screening
Milton Weinstein, PhD

Risk-based Screening for Early Detection of Breast Cancer in Younger Women
Sandra J. Lee, ScD


Image Analysis and Imaging Biomarkers in Oncology

May 18, 2009
CLSB Building, 3 Blackfan Circle, Room 11081

Mechanistic Neuroimaging in Glioblastoma
Gregory Sorensen, MD

Evaluating response to novel cancer therapy with PET/CT imaging:early development to global multi-center trials
Jeffrey Yap, PhD

Statistical Parametric Imaging for Response Assessment of Novel Therapy in Neuro-Oncology
Armin Schwartzman, PhD

Challenges in Understanding and Coping with Health Disparities

March 12, 2008
Smith Family Room, Dana-Farber Cancer Institute

Addressing Disparities in Cancer Risk-Related Behaviors
Glorian Sorensen, MPH, Ph.D.
Professor of Society, Human Development and Health, Harvard School of Public Health,Director, Center for Community-Based Research, Dana-Farber Cancer Institute

Understand Racial Disparities in Cancer Cures: Results from Large Population Science Studies
Yi Li, Ph.D.
Associate Professor of Biostatistics, Dana-Farber Cancer Institute and Harvard School of Public Health

Design and Analysis Challenges in Dyad-Based Randomized Trials: An application to an ongoing couple-based intervention trial.
Scarlett Bellamy, Ph.D.
Assistant Professor of Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine